MET and epithelial to mesenchymal transition as novel targets in small cell lung cancer
Small cell lung carcinoma (SCLC) is a highly lethal disease due to its chemorefractory nature after first line treatment. The mechanisms to overcome this resistance have remained elusive to tackle up to date. MET is a transmembrane tyrosine kinase receptor and its activation is associated with incre...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Doctoral Thesis |
| Language: | English |
| Published: |
Universitat Pompeu Fabra
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10803/128576 |